Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Innoviva's Liabilities and Shareholders Equity rose 1603.54% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 billion, marking a year-over-year increase of 705.53%. This contributed to the annual value of $1.3 billion for FY2024, which is 462.83% up from last year.
  • Latest data reveals that Innoviva reported Liabilities and Shareholders Equity of $1.4 billion as of Q3 2025, which was up 1603.54% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Innoviva's Liabilities and Shareholders Equity ranged from a high of $1.4 billion in Q3 2025 and a low of $789.2 million during Q2 2021
  • Its 5-year average for Liabilities and Shareholders Equity is $1.2 billion, with a median of $1.2 billion in 2024.
  • Per our database at Business Quant, Innoviva's Liabilities and Shareholders Equity skyrocketed by 4964.54% in 2022 and then tumbled by 1051.49% in 2023.
  • Over the past 5 years, Innoviva's Liabilities and Shareholders Equity (Quarter) stood at $926.4 million in 2021, then soared by 32.93% to $1.2 billion in 2022, then rose by 0.98% to $1.2 billion in 2023, then rose by 4.63% to $1.3 billion in 2024, then increased by 9.84% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.3 billion during Q1 2025.